141 related articles for article (PubMed ID: 38709695)
1. Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma.
Ramirez F; Vasquez R; Gill J; Riva H; Zambrano A; Samaniego M; Fernandez L; Chacon J
J Drugs Dermatol; 2024 May; 23(5):311-315. PubMed ID: 38709695
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy Treatment Disparities: A Texas Cancer Registry Analysis of Patients with Cutaneous Melanoma.
Ramirez F; Alvarado L; Dwivedi A; Chacon J
J Immigr Minor Health; 2024 Feb; 26(1):23-33. PubMed ID: 37615821
[TBL] [Abstract][Full Text] [Related]
3. The impact of demographics, socioeconomics, and health care access on melanoma outcomes.
Cortez JL; Vasquez J; Wei ML
J Am Acad Dermatol; 2021 Jun; 84(6):1677-1683. PubMed ID: 32783908
[TBL] [Abstract][Full Text] [Related]
4. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes.
Harvey VM; Patel H; Sandhu S; Wallington SF; Hinds G
Cancer Control; 2014 Oct; 21(4):343-9. PubMed ID: 25310216
[TBL] [Abstract][Full Text] [Related]
5. Rural Health Disparities in Skin Cancer Amplified Among Skin of Color.
Lin RR; Lee J; Maderal AD; Elman SA
J Drugs Dermatol; 2024 Jun; 23(6):480-484. PubMed ID: 38834209
[TBL] [Abstract][Full Text] [Related]
6. Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Immunother; 2019; 42(6):228-235. PubMed ID: 30985445
[TBL] [Abstract][Full Text] [Related]
7. Does Universal Insurance and Access to Care Influence Disparities in Outcomes for Pediatric Patients with Osteomyelitis?
Young JD; Dee EC; Levine A; Sturgeon DJ; Koehlmoos TP; Schoenfeld AJ
Clin Orthop Relat Res; 2020 Jul; 478(7):1432-1439. PubMed ID: 31725027
[TBL] [Abstract][Full Text] [Related]
8. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
Moyers JT; Patel A; Shih W; Nagaraj G
JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
[TBL] [Abstract][Full Text] [Related]
9. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
10. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Kandolf Sekulovic L; Peris K; Hauschild A; Stratigos A; Grob JJ; Nathan P; Dummer R; Forsea AM; Hoeller C; Gogas H; Demidov L; Lebbe C; Blank C; Olah J; Bastholt L; Herceg D; Neyns B; Vieira R; Hansson J; Rutkowski P; Krajsova I; Bylaite-Bucinskiene M; Zalaudek I; Maric-Brozic J; Babovic N; Banjin M; Putnik K; Weinlich G; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Kukushkina M; De La Cruz Merino L; Ymeri A; Risteski M; Garbe C
Eur J Cancer; 2017 Apr; 75():313-322. PubMed ID: 28264791
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic Status and Melanoma in Canada: A Systematic Review.
Li HO; Bailey AJ; Grose E; McDonald JT; Quimby A; Johnson-Obaseki S; Nessim C
J Cutan Med Surg; 2021; 25(1):87-94. PubMed ID: 32955341
[TBL] [Abstract][Full Text] [Related]
12. Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma.
Kakish H; Pawar O; Bhatty M; Doh S; Mulligan KM; Rothermel LD; Bordeaux JS; Mangla A; Hoehn RS
Am J Clin Oncol; 2024 May; 47(5):239-245. PubMed ID: 38251734
[TBL] [Abstract][Full Text] [Related]
13. Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Moss JL; Murphy J; Filiaci VL; Wenzel LB; Minasian L; Temkin SM
Support Care Cancer; 2019 Feb; 27(2):531-538. PubMed ID: 30003341
[TBL] [Abstract][Full Text] [Related]
14. Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: What is driving disparities in receipt of treatment?
Lee RM; Liu Y; Gamboa AC; Zaidi MY; Kooby DA; Shah MM; Cardona K; Russell MC; Maithel SK
J Surg Oncol; 2019 Sep; 120(4):611-623. PubMed ID: 31301148
[TBL] [Abstract][Full Text] [Related]
15. Health Disparities Influence Childhood Melanoma Stage at Diagnosis and Outcome.
Hamilton EC; Nguyen HT; Chang YC; Eberth JM; Cormier J; Elting LS; Austin MT
J Pediatr; 2016 Aug; 175():182-7. PubMed ID: 27233520
[TBL] [Abstract][Full Text] [Related]
16. Health care inequities: an introduction for dermatology providers.
Sauaia A; Dellavalle RP
Dermatol Clin; 2009 Apr; 27(2):103-7, v. PubMed ID: 19254652
[TBL] [Abstract][Full Text] [Related]
17. Social determinants of health and health disparities in glaucoma: A review.
Acuff K; Wu JH; Varkhedi V; Baxter SL
Clin Exp Ophthalmol; 2024 Apr; 52(3):276-293. PubMed ID: 38385607
[TBL] [Abstract][Full Text] [Related]
18. Disparities of Immunotherapy Utilization in Patients with Stage III Cutaneous Melanoma: A National Perspective.
Al-Qurayshi Z; Crowther JE; Hamner JB; Ducoin C; Killackey MT; Kandil E
Anticancer Res; 2018 May; 38(5):2897-2901. PubMed ID: 29715114
[TBL] [Abstract][Full Text] [Related]
19. [Social disparities in outpatient and inpatient care: An overview of current findings in Germany].
Klein J; von dem Knesebeck O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Feb; 59(2):238-44. PubMed ID: 26631009
[TBL] [Abstract][Full Text] [Related]
20. Addressing the Root Cause: Rising Health Care Costs and Social Determinants of Health.
Bush M
N C Med J; 2018; 79(1):26-29. PubMed ID: 29439099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
